GNCA
Genocea Biosciences, Inc.
GNCA
GNCA
Delisted
GNCA was delisted on the 2nd of June, 2022.
40 hedge funds and large institutions have $65.3M invested in Genocea Biosciences, Inc. in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
18% less capital invested
Capital invested by funds: $79.4M → $65.3M (-$14.1M)
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
Holders
40
Holding in Top 10
2
Calls
$388K
Puts
$140K
Top Buyers
| 1 | +$294K | |
| 2 | +$289K | |
| 3 | +$175K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$80.3K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$47.3K |
Top Sellers
| 1 | -$204K | |
| 2 | -$185K | |
| 3 | -$164K | |
| 4 |
PCM
Prelude Capital Management
New York
|
-$102K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$45K |